Selank 10mg
LatestLOT SLK0002
99.49%HPLC purity · meets spec
- Labeled
- 10mg
- Measured
- 10.62mg
- Identity
- Confirmed
- Heavy metals
- Not Detected
- Sterility
- No Growth
- Endotoxin
- < 0.05 EU/mL
- Tested
- Jul 30, 2026
8 assays passed · ISO/IEC 17025 accredited
Cognitive & Anxiolytic Peptide
SELANK
TP-7SelancThr-Lys-Pro-Arg-Pro-Gly-ProCAS: 129954-34-3
A 7-amino acid synthetic heptapeptide derived from tuftsin that modulates GABAergic neurotransmission and BDNF expression, studied for anxiolytic and nootropic effects in clinical studies. Premium Direct-Supply Peptide.
MassChoose an option
Quantity
From$64
Fast, protected deliveryTracked USA shipping with discreet packaging.
Tracked USA delivery
Free shipment protection
Priority shipping available
Verified Test Results
Every batch, independently verified.
Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory. The report below reflects the identity, purity and full-panel specification data reported by the lab.
ILSILS LaboratoriesCertificate of Analysis≥99%Purity by HPLC
ISO 17025 Accredited8× Tested
ParameterResultMethodSpecification
Peptide Purity (HPLC)99.49%HPLC>= 95%
Net Peptide Content10.62mgHPLCReport
Identity (HPLC)ConfirmedHPLCMeets spec
AppearanceGoodVisualMeets spec
Fentanyl ScreenNot DetectedImmunoassayPass
Heavy Metals (ICP-MS)Not DetectedICP-MSPass
Sterility (PCR)No GrowthPCRPass
Endotoxin (USP <85>)< 0.05 EU/mLUSP <85>Reported
Third-Party Verified
Certificate of Analysis
Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch's certificate below.
Frequently Paired Products
Products commonly selected alongside this item
Compound Information
Technical specifications
MOLECULAR PROFILE
What Is Selank?
Synthetic heptapeptide analog of tuftsin, an immunomodulatory tetrapeptide derived from IgG
HeptapeptideTuftsin Analog
- Type
- Synthetic heptapeptide
- CAS Number
- 129954-34-3
- Molecular Formula
- C33H57N11O9
- Molecular Weight
- 751.9 g/mol
- Amino Acids
- 7 residues
- Sequence
- Thr-Lys-Pro-Arg-Pro-Gly-Pro
STORAGE REQUIREMENTS
Stability Information
Handle with care to maintain potencyLight sensitiveTemperature sensitive
Lyophilized (powder)-20°Cprotect from light
Reconstituted2-8°C
Nasal spray (0.15%)2-8°C30 days after opening
DEVELOPMENT STATUS
Regulatory Information
Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences
- Developer
- Russian Academy of Sciences
- Collaborator
- V.V. Zakusov Institute
- Approval
- Russia (2009), Ukraine
- Indication
- Generalized Anxiety Disorder
- US Status
- Not FDA-approved
- Formulation
- 0.15% nasal drops (Rx in Russia)
Product Guides & References
Verified publications and source documentation
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S.S. KORSAKOVA
Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia
2008•PMID: 18454096Zozulia AA, Neznamov GG, Siuniakov TS, et al.
View Source BEHAVIOURAL NEUROLOGYPeptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats
2017•DOI: 10.1155/2017/5091027•PMID: 28280289Kasian A, Kolomin T, Andreeva L, et al.
View Source FRONTIERS IN PHARMACOLOGYSelank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission
2016•DOI: 10.3389/fphar.2016.00031•PMID: 26924987Volkova A, Shadrina M, Kolomin T, et al.
View Source BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINESelank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats
2019•PMID: 31625062Kozlovskii II, Andreeva LA, Myasoedov NF
View Source ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S.S. KORSAKOVAA comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders
2014•PMID: 25176261Medvedev VE, Tereshchenko ON, Israelian AIu, et al.
View Source BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINEThe inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity
2001•PMID: 11550013Zozulya AA, Kost NV, Yu Sokolov O, et al.
View Source BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINEThe Influence of Selank on the Level of Cytokines Under Conditions of Experimental Immunodeficiency
2020•PMID: 32621722
View Source PHARMACOKINETIC DATA
